We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Vir Biotechnology
VIR
$1.5B
| $2.32M | ﹤0.01% |
228,687
-46,771
| -17% | -$476K |
|
1827
RPC Inc
RES
$1.36B
| $2.32M | ﹤0.01% |
299,132
+6,470
| +2% | +$46.7K |
|
1828
Mitsubishi UFJ Financial
MUFG
$251B
| $2.31M | ﹤0.01% |
226,241
+7,278
| +3% | +$70.4K |
|
1829
Regenxbio
RGNX
$688M
| $2.31M | ﹤0.01% |
109,539
-1,792
| -2% | -$31.9K |
|
1830
Kymera Therapeutics
KYMR
$9.03B
| $2.31M | ﹤0.01% |
57,392
+3,889
| +7% | +$139K |
|
1831
Weis Markets
WMK
$1.78B
| $2.29M | ﹤0.01% |
35,494
+312
| +0.9% | +$19.5K |
|
1832
Keros Therapeutics
KROS
$212M
| $2.29M | ﹤0.01% |
34,527
+2,870
| +9% | +$170K |
|
|
AAMI
1833
Acadian Asset Management
AAMI
$3.22B
| $2.28M | ﹤0.01% |
100,041
-254
| -0.3% | -$5.47K |
|
|
INN
1834
Summit Hotel Properties
INN
$670M
| $2.28M | ﹤0.01% |
350,933
+4,550
| +1% | +$29.7K |
|
1835
LegalZoom.com
LZ
$973M
| $2.28M | ﹤0.01% |
170,996
+15,634
| +10% | +$180K |
|
1836
TriCo Bancshares
TCBK
$1.82B
| $2.28M | ﹤0.01% |
62,016
-3,741
| -6% | -$136K |
|
1837
United Natural Foods
UNFI
$2.8B
| $2.28M | ﹤0.01% |
198,009
+2,811
| +1% | +$40.8K |
|
1838
Eagle Bancorp
EGBN
$843M
| $2.27M | ﹤0.01% |
96,698
+61
| +0.1% | +$1.51K |
|
1839
InMode
INMD
$873M
| $2.27M | ﹤0.01% |
105,094
+3,145
| +3% | +$70.3K |
|
1840
Fastly Inc
FSLY
$4.42B
| $2.27M | ﹤0.01% |
175,019
+5,016
| +3% | +$84.8K |
|
1841
Pediatrix Medical
MD
$2.12B
| $2.27M | ﹤0.01% |
225,901
+569
| +0.3% | +$5.29K |
|
1842
Cytek Biosciences
CTKB
$606M
| $2.26M | ﹤0.01% |
337,312
+9,682
| +3% | +$76.6K |
|
1843
Monarch Casino & Resort
MCRI
$2.17B
| $2.26M | ﹤0.01% |
30,153
+87
| +0.3% | +$6.03K |
|
1844
Plug Power
PLUG
$2.94B
| $2.26M | ﹤0.01% |
657,286
-151,493
| -19% | -$563K |
|
1845
Recursion Pharmaceuticals
RXRX
$1.76B
| $2.26M | ﹤0.01% |
226,772
+7,705
| +4% | +$85.8K |
|
1846
Hain Celestial
HAIN
$53.4M
| $2.26M | ﹤0.01% |
287,375
+3,798
| +1% | +$37.4K |
|
1847
ACM Research
ACMR
$5.49B
| $2.25M | ﹤0.01% |
77,264
+2,080
| +3% | +$47.6K |
|
1848
Live Oak Bancshares
LOB
$1.95B
| $2.25M | ﹤0.01% |
54,233
+690
| +1% | +$27.5K |
|
1849
Nu Skin
NUS
$250M
| $2.25M | ﹤0.01% |
162,681
+3,094
| +2% | +$48.3K |
|
|
HOUS
1850
DELISTED
Anywhere Real Estate
HOUS
| $2.25M | ﹤0.01% |
363,751
+6,300
| +2% | +$41.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.